Sodium Bicarbonate Injection, Solution
Product Images NDC 83854-001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sodium Bicarbonate (NDC 83854-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Anthea Pharma Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Carton Label Spl 20s)

FDA Label Image

"image Description" (Carton Label Spl 25s)

"image Description" (Carton Label Spl 25s)
This text provides information about an 8.4% Sodium Bicarbonate injection in a specific area for a particular purpose related to cooking. It mentions the specific formula and type of Sodium Bicarbonate along with the abbreviation "USP." No further details are available from the provided text.*
FDA Label Image

"image Description" (Container Lebel Spl)

"image Description" (Container Lebel Spl)
This is a description of a pharmaceutical product with the National Drug Code (NDC) 83854-001-01. It is a sterile, nonpyrogenic injection containing 8.4% Sodium Bicarbonate with each milliliter containing 84 mg of sodium bicarbonate and having a pH range of 7.0 to 8.5. The solution is for intravenous use only and should be stored at 20°C to 25°C (68°F to 77°F). The product is manufactured by Anthea Pharma Private Limited in Hyderabad, India. The vial also indicates to discard any unused portion and includes dimensions for an unvarnished area for overcoding.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.